全文获取类型
收费全文 | 208篇 |
免费 | 9篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 12篇 |
妇产科学 | 2篇 |
基础医学 | 13篇 |
口腔科学 | 2篇 |
临床医学 | 50篇 |
内科学 | 48篇 |
皮肤病学 | 1篇 |
神经病学 | 4篇 |
特种医学 | 53篇 |
外科学 | 14篇 |
综合类 | 3篇 |
预防医学 | 12篇 |
药学 | 4篇 |
肿瘤学 | 6篇 |
出版年
2022年 | 1篇 |
2021年 | 2篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 1篇 |
2016年 | 1篇 |
2015年 | 3篇 |
2014年 | 1篇 |
2013年 | 5篇 |
2012年 | 1篇 |
2011年 | 1篇 |
2010年 | 4篇 |
2009年 | 8篇 |
2008年 | 1篇 |
2007年 | 10篇 |
2006年 | 5篇 |
2005年 | 3篇 |
2004年 | 5篇 |
2003年 | 7篇 |
2002年 | 1篇 |
2001年 | 3篇 |
2000年 | 1篇 |
1999年 | 5篇 |
1998年 | 10篇 |
1997年 | 5篇 |
1996年 | 9篇 |
1995年 | 5篇 |
1994年 | 16篇 |
1993年 | 11篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1989年 | 11篇 |
1988年 | 10篇 |
1987年 | 14篇 |
1986年 | 7篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1969年 | 1篇 |
排序方式: 共有224条查询结果,搜索用时 656 毫秒
21.
22.
J A Janssen P J Blankestijn R Docter B G Blijenberg S W Lamberts E P Krenning 《Nederlands tijdschrift voor geneeskunde》1989,133(29):1455-1458
The use of monoclonal antibodies in medicine for in-vivo diagnostic methods and for therapeutic purposes will increase in the future. Although monoclonal antibodies possess a high specificity, the animal origin of these antibodies remains a problem. Repeated administration of animal monoclonal antibodies (in vivo) may induce the formation of human antibodies against these monoclonal antibodies. Because animal monoclonal antibodies are also used in laboratory assays (in vitro), the presence of human antibodies against these animal monoclonal antibodies may cause spuriously elevated or depressed results of these assays. The clinician should be alert to this possibility. A case history is presented to demonstrate the problem. 相似文献
23.
Rubin JI; Arger PH; Pollack HM; Banner MP; Coleman BG; Mintz MC; VanArsdalen KN 《Radiology》1987,162(1):21
24.
Lilian A Inocencio Anderson A Pereira Maria Cecilia A Sucupira Jos Carlos C Fernandez Clia P Jorge Denise FC Souza Helena T Fink Ricardo S Diaz Irina M Becker Theodoro A Suffert Monica B Arruda Olinda Macedo Mariangela BG Simo Amilcar Tanuri 《Journal of the International AIDS Society》2009,12(1):20-20
25.
Stephan C Xu C Cammann H Graefen M Haese A Huland H Semjonow A Diamandis EP Remzi M Djavan B Wildhagen MF Blijenberg BG Finne P Stenman UH Jung K Meyer HA 《World journal of urology》2007,25(1):95-103
Use of percent free PSA (%fPSA) and artificial neural networks (ANNs) can eliminate unnecessary prostate biopsies. In a total
of 4,480 patients from five centers with PSA concentrations in the range of 2–10 ng/ml an IMMULITE PSA-based ANN (iANN) was
compared with other PSA assay-adapted ANNs (nANNs) to investigate the impact of different PSA assays. ANN data were generated
with PSA, fPSA (assays from Abbott, Beckman, DPC, Roche or Wallac), age, prostate volume, and DRE status. In 15 different
ROC analyses, the area under the curve (AUC) in the PSA ranges 2–4, 2–10, and 4–10 ng/ml for the nANN was always significantly
larger than the AUC for %fPSA or PSA. The nANN and logistic regression models mostly also performed better than the iANN.
Therefore, for each patient population, PSA assay-specific ANNs should be used to optimize the ANN outcome in order to reduce
the number of unnecessary biopsies. 相似文献
26.
Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer. 总被引:1,自引:0,他引:1
B G Blijenberg G Yurdakul B D Van Zelst C H Bangma M F Wildhagen F H Schr?der 《BJU international》2001,88(6):545-550
OBJECTIVE: To assess the value of applying rigid threshold values in interpreting prostate specific antigen (PSA) results, by selecting and comparing five current methods for measuring free and total PSA. MATERIALS AND METHODS: Samples taken from an ongoing screening study for prostate cancer (total PSA by Tandem-E assay, 17 334 participants; biopsy criterion a PSA of 3.0 microg/L, 4 464 men) from men with a total PSA of 1.0-6.0 microg/L were measured for free and total PSA using the Access, Immulite, Elecsys and Prostatus analysis kits, in two patient groups, i.e. with prostate cancer or no evidence of disease. RESULTS: Both patient groups had equal means for total PSA but not for free PSA. In all, 360 samples from men with cancer and 96 from men with no evidence of disease were analysed. All methods applied to both groups deviated statistically significantly from the Tandem-E result for total PSA, except for the Access kit. There was a close correlation among all the methods (correlation coefficients of 0.89-0.97). There were very discordant results for the combination of the Tandem-E vs Prostatus (8% difference), representing 315 participants at a threshold of 3.0 microg/L. For free PSA (free/total PSA) the situation was worse, with extreme differences of 32% and 36% for both patient groups (Elecsys vs Access). CONCLUSIONS: Depending on the threshold value applied as an indication for biopsy, when using the total PSA alone or combined with the free/total PSA, care is needed in interpreting patient groups because of the discordance among PSA assays. 相似文献
27.
28.
29.
Increased expression of the G gamma and A gamma globin genes associated with a mutation in the A gamma enhancer 总被引:1,自引:0,他引:1
Balta G; Brickner HE; Takegawa S; Kazazian HH Jr; Papayannopoulou T; Forget BG; Atweh GF 《Blood》1994,83(12):3727-3737
We have previously described a unique type of delta beta-thalassemia in a Chinese family characterized by increased expression of the G gamma and A gamma fetal globin genes in the absence of a large deletion in the beta-globlin gene cluster. Our earlier study of the beta-globin gene on this delta beta-thalassemia chromosome showed a promoter mutation in the TATA box. In this report, we describe the results of our study of the fetal globin domain of this delta beta-thalassemia chromosome. We have cloned a 13-kb DNA fragment that includes the G gamma and the A gamma genes and the 3' A gamma enhancer element of this delta beta-thalassemia chromosome. DNA sequence analysis of the G gamma and A gamma-globin genes including their promoters did not show any mutations, but analysis of the putative enhancer element downstream from the A gamma-globin gene showed a C to T substitution 2,401 nucleotides downstream from the A gamma cap site. We performed DNA linkage analysis to determine if this mutation is unique to this chromosome or represents a common polymorphism. Our linkage analysis showed that this mutation is not a common polymorphism and that it is also not an intrinsic part of the haplotype of the chromosome on which it was found. We also studied the interaction of nuclear proteins from erythroid and nonerythroid cells with the DNA sequences surrounding this mutation. We have shown by in vitro DNase I footprinting that this mutation falls within a region that is occupied by a novel DNA-binding protein that binds to this site in nuclear extracts from erythroid, but not nonerythroid cells. The binding of this nuclear protein to DNA appears to be dependent on GATA-1 binding to an adjacent GATA-1 site. We have also developed a new functional assay to compare the activity of the normal and mutant A gamma enhancer elements in erythroid cells. Analysis of the activity of the mutant enhancer shows that the mutation completely eliminates all enhancer activity in this assay. These findings suggest that this mutation of the A gamma enhancer on a chromosome that carries a partially inactivated beta-globin gene may be responsible for the increased expression of both gamma-globin genes seen in this condition. 相似文献
30.
Hereditary elliptocytosis (HE) is a heterogeneous disorder of red blood cells frequently associated with abnormal limited tryptic digestion of the alpha I domain of spectrin and impaired spectrin dimer self- association. We studied two related individuals with poikilocytic hereditary elliptocytosis (HE) of different severity. Limited tryptic digestion of spectrin from these individuals showed the presence of a variant alpha I/50b Kd peptide at the expense of the normal alpha I/80 Kd peptide. Amino acid sequence analysis of the abnormal peptide showed that the proteolytic cleavage occurred after the arginine at position 470 of the alpha spectrin chain. Spectrin from these patients had an impaired ability to undergo self-association, as evidenced by increased amounts of spectrin dimers in 4 degrees C extracts of erythrocyte membrane from affected individuals. The polymerase chain reaction was used to study the DNA sequence of the alpha spectrin gene encoding the region of the alpha spectrin chain surrounding the abnormal proteolytic cleavage site. We detected the in-frame deletion of the trinucleotide CAT, encoding histidine 469, two amino acid residues to the N-terminal side of the abnormal proteolytic cleavage site between residues 470 and 471. Similar to many other defects of spectrin associated with HE, this deletion occurs in helix three of repeat 5 of the proposed triple helical model of spectrin repeats. 相似文献